Finance

Lists
LTGO:NASDAQ
Latigo Biotherapeutics, Inc.
$21.54
-5.53%
(-1.26) 1D
$21.35
-0.88% (-0.19)
After hours
Closed: Sep 10, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for LTGO...
Open
$22.78
High
$23.17
Low
$21.28
Avg. vol.
278.58K
Volume
0.00
52-wk high
$25.90
52-wk low
$17.22
No. of employees
66
Open
$22.78
High
$23.17
Low
$21.28
Avg. vol.
278.58K
Volume
0.00
52-wk high
$25.90
52-wk low
$17.22
No. of employees
66
About Latigo Biotherapeutics, Inc.
CEO-
Employees66
Founded2018
Headquarters-
SectorPharmaceutical industry
Analyst ratings
Based on 3 analysts giving stock ratings to LTGO in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for LTGO in the last 3 months.
Highest
Current $21.54
$73.00 (+238.90%)
Average
$57.67 (+167.73%)
Lowest
$50.00 (+132.13%)
Analyst
Recommendation
Action
Price target
Projected
Date
Yatin Suneja
Guggenheim
Buy
Initiated
$50.00
+132.1%
09/01/2026
Akash Tewari
Jefferies
Buy
Initiated
$50.00
+132.1%
09/01/2026
Salveen Richter
Goldman Sachs
Buy
Maintained
$73.00
+238.9%
09/03/2026
Awaiting results...
Call Time: Thu, Sep 3, 4:00 PM
Fiscal period
Q2 2026
EPS / Est. (USD)
- / -$0.81
Revenue / Est. (USD)
- / 0.00
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
18.69M
-
17.63M
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.82M
-
5.80M
-
Operating expense
21.51M
-
23.44M
-
Total operating expenses
21.51M
-
23.44M
-
Operating income
-21.51M
-
-23.44M
-
Other non operating income
43.00K
-
1.00K
-
EBT including unusual items
-20.95M
-
-22.96M
-
EBT excluding unusual items
-20.95M
-
-22.96M
-
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-20.95M
-
-22.96M
-
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
517.00K
-
474.00K
-
Interest expense
-
-
-
-
Net interest expenses
517.00K
-
474.00K
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-21.44M
-
-23.39M
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google apps